TSX News -
Interfor Appoints Christina Sistrunk to its Board of Directors
BURNABY, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) is pleased to […]
NewtekOne, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Full Year 2023 Basic Earnings per Share of $1.71 and Diluted Earnings per Share of $1.70 Conference Call Tomorrow 8:30 […]
F&M Bank Announces Promotion of Kevin Becker to Chief Credit Officer
ARCHBOLD, Ohio, March 05, 2024 (GLOBE NEWSWIRE) — F&M Bank (“F&M”), an Archbold, Ohio based bank owned by Farmers & […]
CoreCivic Announces Upsizing and Pricing of $500 Million 8.25% Senior Notes Due 2029
BRENTWOOD, Tenn., March 05, 2024 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (“CoreCivic”) announced today that it successfully upsized and […]
TSX News -
AGF Management Limited to Release First Quarter 2024 Financial Results on April 4, 2024
TORONTO, March 05, 2024 (GLOBE NEWSWIRE) — AGF Management Limited (TSX: AGF.B) will release its financial results for Q1 2024 […]
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PHILADELPHIA, March 05, 2024 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell […]
TSX News -
Troilus Closes Strategic Sale of Non-Core Mike Lake Properties in Yukon to Prospector Metals; Retains ~20% Ownership Interest
MONTREAL, March 05, 2024 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) (“Troilus” or the “Company”) […]
TSX News -
AGF REPORTS February 2024 ASSETS UNDER MANAGEMENT and FEE-EARNING ASSETS
TORONTO, March 05, 2024 (GLOBE NEWSWIRE) — AGF Management Limited reported total assets under management (AUM) and fee-earning assets1 of […]
Genie Energy to Report Fourth Quarter and Full Year 2023 Results
NEWARK, NJ, March 05, 2024 (GLOBE NEWSWIRE) — Genie Energy Ltd., (NYSE: GNE, GNEPRA), a leading retail energy and renewable […]
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Preclinical data support future clinical development of ADCs targeting Claudin-6 and NaPi2b Additional presentations include clinical and independent preclinical studies […]
